These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 9350688)

  • 1. Immune dysfunction in uremia.
    Cohen G; Haag-Weber M; Hörl WH
    Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of polymorphonuclear leukocytes in uremia.
    Haag-Weber M; Hörl WH
    Semin Nephrol; 1996 May; 16(3):192-201. PubMed ID: 8734462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide isolated from a patient on continuous ambulatory peritoneal dialysis has homology to ubiquitin and inhibits the chemotactic response of polymorphonuclear leukocytes.
    Cohen G; Rudnicki M; Hörl WH
    Miner Electrolyte Metab; 1997; 23(3-6):210-3. PubMed ID: 9387119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uraemia?
    Haag-Weber M; Hörl WH
    Nephrol Dial Transplant; 1996; 11 Suppl 2():98-100. PubMed ID: 8804005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune system in uremia and during its treatment.
    Haag-Weber M; Hörl WH
    New Horiz; 1995 Nov; 3(4):669-79. PubMed ID: 8574597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of malnutrition and uremia on impaired cellular host defence.
    Haag-Weber M; Dumann H; Hörl WH
    Miner Electrolyte Metab; 1992; 18(2-5):174-85. PubMed ID: 1465054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions.
    Cohen G; Haag-Weber M; Mai B; Deicher R; Hörl WH
    J Am Soc Nephrol; 1995 Dec; 6(6):1592-9. PubMed ID: 8749685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cellular host defence in peritoneal dialysis by two granulocyte inhibitory proteins.
    Haag-Weber M; Mai B; Hörl WH
    Nephrol Dial Transplant; 1994; 9(12):1769-73. PubMed ID: 7708262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.
    Cohen G; Raupachova J; Wimmer T; Deicher R; Hörl WH
    Nephrol Dial Transplant; 2008 Aug; 23(8):2512-9. PubMed ID: 18319358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis and neutrophil bactericidal capacity in patients with uremia.
    Wierusz-Wysocka B; Wysocki H; Michta G; Wykretowicz A; Czarnecki R; Baczyk K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):589-94. PubMed ID: 6083931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune status of the uremic patient: hemodialysis vs CAPD.
    Schollmeyer P; Bozkurt F
    Clin Nephrol; 1988; 30 Suppl 1():S37-40. PubMed ID: 3052959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a granulocyte inhibitory protein from uraemic patients with homology of beta 2-microglobulin.
    Haag-Weber M; Mai B; Hörl WH
    Nephrol Dial Transplant; 1994; 9(4):382-8. PubMed ID: 8084451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phagocyte function in uremic patients].
    Ringoir S; Vanholder R
    Verh K Acad Geneeskd Belg; 1991; 53(3):189-201; discussion 201-3. PubMed ID: 1927026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
    Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G
    Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil beta(2)-microglobulin and lactoferrin content in renal failure patients.
    Deicher R; Exner M; Cohen G; Haag-Weber M; Hörl WH
    Am J Kidney Dis; 2000 Jun; 35(6):1117-26. PubMed ID: 10845826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin as a uremic toxin interferes with neutrophil chemotaxis.
    Ottonello L; Gnerre P; Bertolotto M; Mancini M; Dapino P; Russo R; Garibotto G; Barreca T; Dallegri F
    J Am Soc Nephrol; 2004 Sep; 15(9):2366-72. PubMed ID: 15339985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity in uremic patients prior to and after 6 months' treatment with continuous ambulatory peritoneal dialysis.
    Shohat B; Boner G; Waller A; Rosenfeld JB
    Isr J Med Sci; 1986; 22(7-8):551-5. PubMed ID: 3491060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune system dysregulation in uremia.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Zingraff J; Jungers P; Chatenoud L
    Semin Nephrol; 1994 May; 14(3):253-60. PubMed ID: 8036360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.